Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Enhancing immune response can improve cancer treatment effectiveness.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Baricitinib was effective in treating alopecia areata in two major trials.

The treatment was effective and tolerable for advanced gastric cancer.

The treatment was effective for lupus nephritis with manageable side effects.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Semaglutide may help some skin disorders but can also cause skin issues.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

Candida antigen is an effective and promising treatment for alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.